Lisa Barroilhet, MD
Lisa Barroilhet, MD, is an assistant professor in the Department of Obstetrics and Gynecology at the University of Wisconsin School of Medicine and Public Health. She is also a gynecologic oncologist at the UW Carbone Cancer Center and an expert in ovarian cancer, drug development, and HPV and cervical cancer screening.
Dr. Barroilhet earned her medical degree from the University of Minnesota. She completed her internship and residency at North Carolina Chapel Hill and a fellowship at Harvard’s Brigham and Women’s Hospital/Dana Farber Cancer Institute in Boston.
Dr. Barroilhet’s research is focused on improving the lives of women at high-risk for developing ovarian cancer. Her current research is aimed at examining a class of drugs that increase oxidative stress in cancer cells, which may ultimately prove to be a valuable option for chemoprevention, allowing women to avoid surgical menopausal and retain their ovaries. She is also working to advance the early detection of ovarian cancer using novel radiotracers and imaging techniques.
Her long-term goal is to reduce the need for ovarian removal, especially in young women, and improve early detection for those patients who retain their reproductive structures.
Elizabeth Felton, MD, PhD
Elizabeth Felton, MD, PhD, is an Assistant Professor in the Department of Neurology at the University of Wisconsin School of Medicine and Public Health. She received her PhD in biomedical engineering in 2007 and her medical degree in 2009, both from the School of Medicine and Public Health’s Medical Scientist Training Program. She completed a neurology residency in 2013 and an epilepsy fellowship in 2015, at Johns Hopkins Hospital.
Dr. Felton is considered an expert in the evaluation and treatment of epilepsy. Her long-term goal is to become an independent investigator focused on developing a personalized medicinal approach for dietary therapy customization and response prediction to reduce seizure burden and comorbidities in women with epilepsy. Her current research focuses on identifying hormonal and cognition/mood effects of ketogenic dietary therapy in women with epilepsy.
She hopes to expand her research program investigating whether other modalities (e.g. neuroimaging, high-density EEG, serologic biomarkers) can be used to further understand the mechanisms of dietary therapy and predict improved health outcomes in women with epilepsy.